The mechanism of induction of apoptosis by the novel anti-cancer drug 1-O-octadecyl-2-methylrac-glycero-3-phosphocholine (ET-18-OCH 3 ) was investigated in p53-defective SV40 immortalized rat hepatocytes (CWSV1). Exposure to 12 M ET-18-OCH 3 for 36 h induced apoptosis as determined using classical morphological features and agarose gel electrophoresis of genomic DNA. Increased levels of reactive oxygen species (ROS) were detected spectrophotometrically using a nitroblue tetrazolium ( 
The anticancer drug 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine (ET-18-OCH 3 ), a synthetic ether phospholipid, inhibits the activity of CTP:phosphocholine cytidylyltransferase, the rate-limiting step in the synthesis of phosphatidylcholine (PC) (1) . It exhibits selective cytotoxicity against many tumor cell types (2) and is known to induce apoptosis (3) . Choline deficiency (CD) limits the availability of phosphocholine, thus effectively limiting the synthesis of PC by CTP: phosphocholine cytidylyltransferase, and triggers a p53-independent form of apoptosis in cultured hepatocytes (4) . The form of apoptosis induced by acute CD appears to be mediated by generation of reactive oxygen species (5) . Although the anti-tumor mechanism of action of ET-18-OCH 3 is unclear, we hypothesized that this drug kills cells in a manner similar to CD.
Evidence suggests that ET-18-OCH 3 is capable of generating increased oxidant stress. Thus, in L1210 leukemia cells, ET-18-OCH 3 increased the generation of lipid-derived free radicals before the appearance of cytotoxic effects (6) , although the generation of free radicals required iron supplementation and prior enrichment of cellular components with polyunsaturated fatty acid. Similarly, ET-18-OCH 3 increased lipid peroxidation in nude mice inoculated with MDA-MB-231 breast carcinoma cells and fed a diet high in fish oils; unfortunately, the effects on apoptosis were not studied (7) . In contrast, overexpression of bcl-2 or bcl-X L , two gene products capable of blocking mitochondrial ROSmediated apoptosis (8 -10) , abrogated ET-18-OCH 3 apoptosis in human leukemia cells.
Mitochondria are the richest source of reactive oxygen species (ROS) in the cell, converting 1-2% of reduced oxygen into superoxide (11) . Inhibition of the mitochondrial electron transport chain, resulting in subsequent release of ROS, is an early event in many forms of apoptosis (e.g., ceramide, dexamethasone, and bleomycin) (8, 12, 13) . However, it is not clear whether all forms of apoptosis are mediated by ROS. This study provides evidence that the anti-cancer drug ET-18-OCH 3 shares some biochemical features with CD and causes a form of p53-independent apoptosis that is mediated by ROS derived from mitochondria.
MATERIALS AND METHODS

Cell culture
SV40-immortalized CWSV1 rat hepatocytes were obtained from Dr. Harriet C. Isom (Department of Microbiology, The Pennsylvania State University College of Medicine, Hershey, PA). This cell line was derived from male Fisher 344 rat liver and was immortalized with the SV40 large T antigen that inactivates p53 protein (14 -17) . The cells retain expression of liver-specific proteins and are routinely grown in a serumfree defined media (16, 17) . CWSV1 hepatocytes were maintained in 70 M choline (CS), serum-free RPMI 1640 medium (American Bioganics, Inc., Niagara Falls, NY) as described previously (4) . All experiments used CWSV1 cells at passage 32-34.
ET-18-OCH 3 and apoptosis
A stock solution (10 mM; 100ϫ) of ET-18-OCH 3 (Calbiochem, La Jolla, CA) was prepared in sterile water and stored at Ϫ20°C. For cell treatment, ET-18-OCH 3 stock was added to cell culture medium to achieve a final concentration of 12 M. The antioxidant ␣-tocopherol succinate (Sigma, St. Louis, MO) was dissolved in sterile absolute ethanol at a concentration of 10 mM (100ϫ) and stored at Ϫ20°C. For cell treatment, ␣-tocopherol was added to cell culture medium to achieve a final concentration of 10 M. Cells were plated at a density of 2 ϫ 10 4 cells per well in 6-well plates (Falcon, Franklin Lakes, NJ) and grown for 2 days. Subconfluent cultures (Ϸ 70% confluent) were treated with ET-18-OCH 3 -containing medium for 36 h. Additional cultures of CWSV1 cells were switched for 48 h from CS (70 M choline) to 0 M choline.
Assessment of apoptosis
Apoptosis was assessed at the end of treatment in attached cells fixed in 70% ethanol and stained with hematoxylin as described previously (4) . The percentage of cells undergoing apoptosis was determined from counts of the number of cells with classical apoptotic morphology in 10 randomly selected microscope fields (10ϫ ocular, 40ϫ objective).
DNA fragmentation associated with apoptosis was also assessed. High and low molecular weight DNA from 2 ϫ 10 6 cells was extracted using DNAzol ™ (Life Technologies, Inc., Gaithersburg, MD) and separated on a 1.8% agarose slab gel containing 1 g/ml ethidium bromide (Sigma).
Quantification of reactive oxygen species
A modified version of a previously described assay for the intracellular conversion of nitro blue tetrazolium (NBT) to formazan by superoxide anion was used to measure the generation of reactive oxygen species (18) . Briefly, 50 M NBT (Sigma) was added to the media at the end of the treatment periods; cells were incubated for an additional 15 min at 37°C, fixed in absolute ethanol, and allowed to air dry.
The formazan content of the cells was then solubilized with 960 l 2M KOH and 1120 l DMSO, and the absorbance at OD 630 nm was measured spectrophotometrically. A standard curve was prepared by adding KOH and DMSO to known amounts of NBT. As a positive control, 100 M hydrogen peroxide was added to cells and the amount of formazan formed was measured.
Isolation of mitochondria and associated membranes
Mitochondria and associated membranes were isolated from cells at the end of the treatment as described previously (19) . Briefly, 1 ϫ 10 7 cells were homogenized in 5 volumes buffer A (20 mM HEPES-KOH, pH 7.5; 10 mM KCl, 1.5 mM MgCl 2 , 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM DTT, 0.1 mM PMSF, 250 mM sucrose, 10 g/ml leupeptin, 5 g/ml pepstatin, and 2 g/ml aprotinin), and the homogenate was subjected to centrifugation at 750 g for 10 min at 4°C. The supernatant was collected and subjected to centrifugation at 750 g for 10 min at 4°C, then the resulting supernatant was transferred and subjected to centrifugation at 10,000 g for 15 min at 4°C. The resulting mitochondrial pellet was resuspended in buffer A and stored frozen at Ϫ80°C until analyzed. Two pellets were processed for transmission electron microscopy (TEM) as described previously (20) .
Measurement of mitochondrial PC
Protein content of isolated mitochondria and associated membranes was determined by the Lowry method (21). Total phospholipids were extracted by the method of Bligh and Dyer (22) , separated by thin-layer chromatography, and phosphatidylcholine mass was determined by inorganic phosphorous determination (23) .
Inhibition of mitochondrial function
Rotenone (Sigma), an inhibitor of complex I of the mitochondrial electron transport chain (24) , was dissolved in tissue Figure 1 . ET-18-OCH 3 causes DNA fragmentation. CWSV1 hepatocytes were cultivated in RPMI-defined medium containing 70 M choline until 70% confluent and then switched for 36 h to the same medium containing 12 M ET-18-OCH 3 . DNA fragmentation was analyzed after electrophoresis in a 1.8% agarose slab gel stained with ethidium bromide. This experiment was replicated three times. culture grade dimethyl sulfoxide (Sigma) to achieve a final concentration of 1 mM (1000ϫ). For cell treatments, rotenone was added to cultures at a final concentration of 50 nM. The solvent concentration in media never exceeded 0.001%.
JC-1 (5,5Ј,6,6Ј-tetramethylbenzimidazolcarbocyanine iodide; Molecular Probes, Inc., Eugene, OR), a lipophilic, cationic molecule that is capable of crossing the plasma membrane and specifically binding to the mitochondrial membrane (25) , was dissolved in tissue culture grade dimethyl sulfoxide at a concentration of 1 mg/ml. After treatments, cells were probed with JC-1 and visualized as described (26) . When taken up by normal cells, JC-1 exists as a monomer that emits at 527 nm (green fluorescence) after excitation at 490 nm; as the mitochondrial membrane polarization changes, JC-1 forms aggregates that are associated with a large shift in emission to 590 nm (red fluorescence) (25, 27) . The potassium ionophore valinomycin was used as a positive control to collapse the mitochondrial membrane potential (26) .
Statistics
Multiple comparisons analysis of variance was performed using Statview 512™ software (Brain Power, Inc., Calabasas, CA).
RESULTS
ET-18-OCH 3 , ROS, and apoptosis
ET-18-OCH 3 treatment of CWSV1 cells produced characteristic apoptotic morphology in attached cells that was accompanied by cleavage of internucleosomal DNA to produce a typical apoptosis-associated DNA ladder (Fig. 1) . Both ET-18-OCH 3 and CD induced overgen- Figure 2 . ET-18-OCH 3 treatment or CD increase generation of intracellular reactive oxygen species and induce apoptosis, which can be abrogated by ␣-tocopherol. A) CWSV1 hepatocytes were cultivated as described in Materials and Methods until 70% confluent and then switched for 36 h to RPMIdefined medium containing 70 M choline (control) and 10 M ␣-tocopherol succinate or 12 M ET-18-OCH 3 ; additional cultures were treated for 48 h with RPMI-defined medium containing 0 M choline (CD). Generation of intracellular ROS was measured by NBT assay. Data are expressed as mean nmol NBT reduced/10 6 cells Ϯ se. n ϭ 5/point. ANOVA with Scheffé's F test: bars with different letter superscripts differ by P Ͻ 0.05. This experiment was replicated twice. B) Cells were fixed with 70% ethanol, stained with hematoxylin, and cells with classical apoptotic nuclear morphology were counted. Data are expressed as percent of cells with apoptotic morphology Ϯ se. n ϭ 6/point. ANOVA with Scheffé's F test: bars with different letter superscripts differ by P Ͻ 0.01. Figure 3 . Inhibition of mitochondrial respiration reduces oxidative stress and abrogates apoptosis. A) CWSV1 hepatocytes were cultivated as described in Materials and Methods until 70% confluent, then switched for 36 h to RPMI-defined medium containing 70 M choline (control) and 50 nM rotenone or 12 M ET-18-OCH 3 plus rotenone; additional cultures were treated with CD (0 M choline) in the presence or absence of 50 nM rotenone. Generation of intracellular ROS was measured by NBT assay. Data are expressed as mean nmol NBT reduced/10 6 cells Ϯ se. n ϭ 5/point. ANOVA with Scheffé's F test: bars with different letter superscripts differ by P Ͻ 0.01. This experiment was replicated once. B) Cells were fixed and analyzed for the induction of apoptosis as described in the legend to Fig. 2 . n ϭ 6/point. ANOVA with Scheffé's F test: bars with different letter superscripts differ by P Ͻ 0.01. eration of ROS that was reduced significantly by simultaneous treatment with the antioxidant ␣-tocopherol ( Fig. 2A) . In addition, in the presence of ␣-tocopherol, ET-18-OCH 3 and CD-induced apoptosis were reduced by 73% and 86%, respectively (Fig. 2B) .
Mitochondria, ROS, and apoptosis
Studies were undertaken to determine whether mitochondria were the source of ROS in this model system. Compared to cells treated with ET-18-OCH 3 or CD alone, treatment with rotenone led to a nearly 85% reduction in the generation of ROS caused by these agents (Fig. 3A) . This effect of rotenone was accompanied by a 59% (ET-OCH 3 ) and 74% (CD) reduction in the level of apoptosis (Fig. 3B) .
Mitochondrial membrane potential
Compared with cells maintained in 70 M choline, which exhibited orange-red JC-1 fluorescence (Fig. 4 , panel CT), CWSV1 hepatocytes treated with CD (0 M choline) medium (Fig. 4, panel CD) or ET-18-OCH 3 (Fig. 4, panel ET) exhibited green JC-1 fluorescence, which is consistent with a loss of mitochondrial membrane polarization. Cells treated with valinomycin alone (positive control) exhibited green fluorescence consistent with a loss of mitochondrial membrane polarization (data not shown). Treatment with rotenone (25 nM) in the presence of CD (Fig. 4, panel CDϩR) or ET-18-OCH 3 (Fig. 4 , panel ETϩR) resulted in a shift in JC-1 fluorescence to orange-red, consistent with a restoration of normal mitochondrial membrane polarization.
Mitochondria and PC
To determine the role of PC synthesis in induction of apoptosis, the PC content of mitochondria and associated membranes was measured in cells that were treated for 24 h with either ET-18-OCH 3 or CD. These agents reduced PC content of mitochondria and associated membranes by 31% and 24%, respectively, compared with controls (70 M choline) ( Table 1) . TEM analysis showed that the mitochondrial preparations contained intact mitochondria and associated endoplasmic reticulum (data are not shown).
DISCUSSION
Since PC plays an important role in maintaining the structural integrity of cell membranes, perturbation of PC synthesis could be an early event in apoptosis signal transduction. We show that the anti-cancer drug ET-18-OCH 3 inhibits PC synthesis and induces generation of ROS, resulting in apoptotic cell death in p53-defective hepatocytes; these observations are similar to those described in acute CD (4, 5, 28) . Previous reports showed that ET-18-OCH 3 inhibited PC synthesis in nonhepatocyte-type cells resulting in an inhibition of cell proliferation (1) and increased apoptosis (29) . However, these studies did not examine whether changes in PC within a plasma membrane or some other membrane were a critical variable. Since both ET-18-OCH 3 and CD decreased mitochondrial PC lev- els and induced apoptosis in CWSV1 cells, and rotenone inhibited both forms of apoptosis, the present data demonstrate an important connection between mitochondrial PC synthesis and the participation of mitochondria in apoptosis signaling. Recent reports demonstrate that perturbations in mitochondrial respiration can occur early in the apoptotic process and that the mitochondrion itself may serve as a control switch for some forms of apoptosis (30, 31) . For example, loss of mitochondrial membrane potential and opening of the mitochondrial membrane megachannel (the so-called permeability transition) have been documented in apoptotic signaling (25, 32, 33) . The occurrence of this permeability transition permits the release of proapoptotic proteins (e.g., cytochrome c, apoptosis-inducing factor) into the cytosol resulting in activation of caspases and endonucleases and the completion of apoptosis (9, 34, 35) .
Some well-controlled studies have shown that complex I of the mitochondrial electron transport chain is an important site for leakage of electrons and subsequent generation of ROS, resulting in completion of apoptosis. To understand the possible role of mitochondria in apoptosis, we modulated the levels of CD and ET-18-OCH 3 in the presence or absence of rotenone, an inhibitor of complex I (NADH-quinone oxidoreductase) of the mitochondrial electron transport chain (36) . Complex I contains a single large inhibitor binding pocket (37) , and binding of different types of inhibitors, including rotenone, prevent overgeneration of ROS and apoptosis-associated DNA cleavage (38, 39) . Rotenone is capable of exerting diverse dosedependent effects on cell survival. In stem-like liver epithelial cells high doses of rotenone (0.5-5 M) induced apoptosis (40, 41) . However, lower doses of rotenone (Յ50 nM) inhibited hydrogen peroxide production, internucleosomal DNA fragmentation, and the morphological appearance of apoptosis in response to C6-ceramide or overexpression of PKC ␦ (13, 42) . CD apoptosis is associated with generation of ceramide (43) and activation of PKC ␦ (44). Thus, our observations with CD-and ET-18-OCH 3 -treated cells are consistent with the previously established apoptosis inhibitory effects of rotenone.
Rotenone itself does not influence PC synthesis directly (45) , so the inhibition of apoptosis we observed must have occurred downstream of the change in PC. The ability of both ET-18-OCH 3 and CD to collapse the mitochondrial membrane potential in CWSV1 cells suggests that mitochondrial generation of ROS per se plays a central role in the completion of both CD and ET-18-OCH 3 apoptosis. Mitochondria are a potential source and target of ROS in cells treated with a variety of proapoptotic agents. In the present study, both ET-18-OCH 3 and CD caused overgeneration of ROS and apoptosis, which were decreased significantly when cells were exposed simultaneously to rotenone, an inhibitor of the mitochondrial electron transport chain. Thus, it is likely that mitochondria are the source of ROS in this model system.
In summary, this study shows that the anti-cancer drug ET-18-OCH 3 causes apoptosis in p53-defective hepatocytes as a consequence of generation of ROS and the loss of mitochondrial membrane potential. Taken together, the results suggest that the induction of structural changes in the mitochondrial membrane because of decreased PC synthesis may play an important role in this form of apoptosis.
